Dr. Martens plc (LON:DOCS) Insider Buys £151.24 in Stock

Dr. Martens plc (LON:DOCSGet Free Report) insider Kenny Wilson bought 199 shares of the business’s stock in a transaction on Wednesday, December 11th. The stock was purchased at an average price of GBX 76 ($0.96) per share, for a total transaction of £151.24 ($190.96).

Kenny Wilson also recently made the following trade(s):

  • On Thursday, September 26th, Kenny Wilson purchased 30,000 shares of Dr. Martens stock. The stock was purchased at an average cost of GBX 55 ($0.69) per share, with a total value of £16,500 ($20,833.33).

Dr. Martens Stock Performance

DOCS stock opened at GBX 76.55 ($0.97) on Monday. Dr. Martens plc has a 1-year low of GBX 49.32 ($0.62) and a 1-year high of GBX 100 ($1.26). The company has a current ratio of 2.85, a quick ratio of 1.13 and a debt-to-equity ratio of 129.55. The firm has a market cap of £736.20 million, a PE ratio of 1,093.57, a P/E/G ratio of 6.40 and a beta of 0.11. The business’s 50-day moving average price is GBX 59.81 and its two-hundred day moving average price is GBX 67.25.

Dr. Martens Cuts Dividend

The firm also recently disclosed a dividend, which will be paid on Tuesday, April 8th. Stockholders of record on Thursday, March 6th will be issued a dividend of GBX 0.85 ($0.01) per share. This represents a dividend yield of 1.47%. The ex-dividend date is Thursday, March 6th. Dr. Martens’s dividend payout ratio (DPR) is presently 4,285.71%.

About Dr. Martens

(Get Free Report)

Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.

Recommended Stories

Insider Buying and Selling by Quarter for Dr. Martens (LON:DOCS)

Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.